NTLA — Intellia Therapeutics, Inc. stock price, charts and financials

QT20Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc. (NASDAQ: NTLA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.32
+0.55+5.11%
OverviewShort InterestFilings
NTLAQT20Intellia Therapeutics, Inc.·NASDAQ
11.32+5.11%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 24, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jun 15, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
May 11, 20268-KCurrent report
May 11, 202610-QQuarterly report
Apr 30, 20268-KCurrent report
Apr 30, 2026DEF 14ADefinitive proxy statement
Apr 30, 2026DEFA14AAdditional proxy soliciting materials
Apr 30, 2026ARSAnnual report to shareholders
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 2026424B5Prospectus
Apr 27, 20268-KCurrent report
Apr 27, 2026424B5Prospectus
Apr 10, 20268-KCurrent report
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 342
Page
▼
/ 14